Login

Kathleen Skarvan, CEO, Electromed Inc 00:00:00

Share On Facebook Share On Twitter

Electromed, Inc ELMD CEO Kathleen Skarvan on 2020 Results

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Hedge Funds 2024: An In-Depth Look at Citco's Performance and Growth in the Middle East with Ziad Chaaban
00:10:00
Juha Saarela, CEO of Puuilo, Reflects on Robust Q1 Performance and Strategic Store Expansion | Juha Saarela, CEO of Puuil OYj.
00:10:00
Queensland Students Engage in Peatland Restoration with Australian Government Support
00:10:00
Analyzing the Fiscal Year 2023 Financial Performance: Insights and Outlook | Alexis Alexiou - CEO of Cenergy Holdings
00:10:00
Assessing Modern Immigration: Challenges and Perspectives|Mark Krikorian
00:10:00
Jan Suykens is CEO of Ackermans & van Haaren, a Belgian diversified holding company active in Marine Engineering & Contracting.|John-Eric Bertrand co-CEO, co-Chairman of the executive committee of Ackermans & van Haaren
00:10:00
Targeting the Lost Generation: Bridging the Age Gap in Broadcasting | Karl Thedéen , CEO of Edgeware AB
00:10:00
Exploring Gold in West Africa: Insights from Fluido's First One-to-One Conference in London
00:10:00
Innovative Pharmaceutical Company Accelerates Growth and Forges Strategic Partnerships |Hartley Atkinson, CEO, AFT Pharmaceuticals Ltd .
00:10:00
Madryn Asset Management is a leading alternative asset management firm that invests in innovative healthcare companies specializing in unique and transformative products, technologies, and services. The firm draws on its extensive and diverse experience s
00:00:00
Mitral valve regurgitation / Abdallah El Sabbagh, M.D. Cardiologist, Mayo Clinic
00:10:00
Generate Biomedicines are working to help cure intractable diseases|Andrew Hedin,Partner,Bessemer Venture Partners

© 2017 - Neuhu+